e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Treatments, adherence and psychosocial aspects of cystic fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Controlled inhalation improves total and peripheral lung deposition in CF
C. Bourke (Perth, Australia), M. Everard (Perth, Australia), S. Devadason (Perth, Australia), W. Ditcham (Perth, Australia), J. Depiazzi (Perth, Australia)
Source:
International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Session:
Treatments, adherence and psychosocial aspects of cystic fibrosis
Session type:
Thematic Poster
Number:
4527
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Bourke (Perth, Australia), M. Everard (Perth, Australia), S. Devadason (Perth, Australia), W. Ditcham (Perth, Australia), J. Depiazzi (Perth, Australia). Controlled inhalation improves total and peripheral lung deposition in CF. 4527
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Measuring peripheral lung dimensions with the deposition of aerosol nanoparticles
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021
Calculation of peripheral airspace dimensions from deposition of inhaled nanoparticles
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016
Deposition of aerosols in the lung periphery of patients with lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 212s
Year: 2001
Pressure supported nasal inhalation improving penetration of particles into the human lung
Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management
Year: 2012
Preservation of post-transplant lung function with aerosol cyclosporin
Source: Eur Respir J 2004; 23: 378-383
Year: 2004
Relationship between CF lung structure and aerosol therapy
Source: Annual Congress 2013 –PG20 Cystic fibrosis: an update of the basic defects and clinical problems in CF children and adults
Year: 2013
Lung deposition of an aerosol produced by a new inhalation device for ventilated patients
Source: Eur Respir J 2005; 26: Suppl. 49, 88s
Year: 2005
Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation
Source: Eur Respir J 2011; 38: 1328-1335
Year: 2011
Reduced lung function and exhaled lining fluid from small airways
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018
Concentration of exhaled endogenous particles in relation to peripheral airway dysfunction
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Exchange of highly soluble gases in the lung airways with the bronchial circulation
Source: Eur Respir J 2004; 24: Suppl. 48, 327s
Year: 2004
Lung function is improved by surfactant pre-treatment in ischemia-reperfusion-injury of the lung
Source: Eur Respir J 2004; 24: Suppl. 48, 204s
Year: 2004
Environmental particulate matter in induced sputum in airway
versus
interstitial lung diseases
Source: Eur Respir J 2007; 30: Suppl. 51, 731s
Year: 2007
Effects of inhaled saline and oxygen on noninvasive markers of airway and lung function
Source: Annual Congress 2012 - New insights in the clinical management of lung diseases
Year: 2012
Comparison of peripheral lung and airway tissue inflammation
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Central airway and peripheral lung structures in airway disease-dominant COPD
Source: ERJ Open Res, 7 (1) 00672-2020; 10.1183/23120541.00672-2020
Year: 2021
Throat deposition of inhaled drug can explain the variability in lung deposition
Source: Eur Respir J 2005; 26: Suppl. 49, 276s
Year: 2005
Influence of pulmonary function on spacer use for HFA-salbutamol inhalation in asthmatic patients
Source: Eur Respir J 2005; 26: Suppl. 49, 126s
Year: 2005
Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Airway length per generation in the human healthy lung and the impact of COPD
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept